AbbVie Inc.
ABBV,
+0.54%
said late Thursday its vice chairman and president will take on the added role of chief operating officer, according to a filing with the Securities and Exchange Commission. The drug maker said it appointed Robert Michael as president and COO. Michael will continue to head global commercial and financial operations, and also be responsible for operations, human resources, business development and corporate strategy, the company said. Shares of AbbVie are down nearly 18% year to date, while the S&P 500 index
SPX,
+0.45%
has gained 14.5%.
Read the full article here